Dehydroeffusol NEW
| Price | $98 | $228 | $397 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-10-11 |
Product Details
| Product Name: Dehydroeffusol | CAS No.: 137319-34-7 |
| Purity: 99.35% | Supply Ability: 10g |
| Release date: 2025/10/11 |
Product Introduction
Bioactivity
| Name | Dehydroeffusol |
| Description | Dehydroeffusol (Dehydro Effusol) possesses anti-cancer, anxiolytic and sedative properties. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis. |
| In vitro | Dehydroeffusol selectively activated the intracellular tumor suppressive stress response by promoting the overexpression of the key ER stress marker DNA damage-inducible transcript 3 (DDIT3), through upregulation of activating transcription factor 4 (ATF4). Concurrently, Dehydroeffusol suppressed the expression of the cell survival and ER stress marker glucose regulated protein of molecular mass 78 (GRP78) via downregulation of the transcription factor ATF6. In addition, Dehydroeffusolmarkedly activated the stress response signaling pathway MEKK4-MKK3/6-p38-DDIT3, but significantly inhibited ERK signaling[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | MMP | Inhibitor | inhibit | GRP78 | ERK | Dehydroeffusol | ATF6 | ATF4 | Apoptosis | Antifection |
| Inhibitors Related | Stavudine | Cysteamine hydrochloride | Doxycycline (hyclate) | Sodium 4-phenylbutyrate | Metronidazole | Citric Acid Triammonium | Doxycycline | Tributyrin | L-Methionine | Cystamine dihydrochloride | Alginic acid | Dextran sulfate sodium salt (MW 5000) |
| Related Compound Libraries | Anti-Tumor Natural Product Library | Polyphenolic Natural Product Library | Pain-Related Compound Library | Bioactive Compound Library | Traditional Chinese Medicine Monomer Library | Rare Natural Product Library | Kinase Inhibitor Library | Natural Product Library | Natural Product Library for HTS | Immunology/Inflammation Compound Library | GPCR Compound Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
![2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimid](https://img.chemicalbook.com/ProductImageEN1/2025-09/Large/2b1033c8-cf09-4545-99b0-c75d04a39088.png)
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/10mg |
Shanghai Standard Technology Co., Ltd.
|
2020-04-29 | ||
| $1.00/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-01-10 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY